Literature DB >> 22693206

High insulin levels are required for FAT/CD36 plasma membrane translocation and enhanced fatty acid uptake in obese Zucker rat hepatocytes.

Xabier Buqué1, Ainara Cano, María E Miquilena-Colina, Carmelo García-Monzón, Begoña Ochoa, Patricia Aspichueta.   

Abstract

In myocytes and adipocytes, insulin increases fatty acid translocase (FAT)/CD36 translocation to the plasma membrane (PM), enhancing fatty acid (FA) uptake. Evidence links increased hepatic FAT/CD36 protein amount and gene expression with hyperinsulinemia in animal models and patients with fatty liver, but whether insulin regulates FAT/CD36 expression, amount, distribution, and function in hepatocytes is currently unknown. To investigate this, FAT/CD36 protein content in isolated hepatocytes, subfractions of organelles, and density-gradient isolated membrane subfractions was analyzed in obese and lean Zucker rats by Western blotting in liver sections by immunohistochemistry and in hepatocytes by immunocytochemistry. The uptake of oleate and oleate incorporation into lipids were assessed in hepatocytes at short time points (30-600 s). We found that FAT/CD36 protein amount at the PM was higher in hepatocytes from obese rats than from lean controls. In obese rat hepatocytes, decreased cytoplasmatic content of FAT/CD36 and redistribution from low- to middle- to middle- to high-density subfractions of microsomes were found. Hallmarks of obese Zucker rat hepatocytes were increased amount of FAT/CD36 protein at the PM and enhanced FA uptake and incorporation into triglycerides, which were maintained only when exposed to hyperinsulinemic conditions (80 mU/l). In conclusion, high insulin levels are required for FAT/CD36 translocation to the PM in obese rat hepatocytes to enhance FA uptake and triglyceride synthesis. These results suggest that the hyperinsulinemia found in animal models and patients with insulin resistance and fatty liver might contribute to liver fat accumulation by inducing FAT/CD36 functional presence at the PM of hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22693206     DOI: 10.1152/ajpendo.00653.2011

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  18 in total

1.  [Conjugated linoleic acid improves glucose and lipid metabolism in diabetic mice].

Authors:  Jun Xia; Mingyue Zheng; Lingjie Li; Xufeng Hou; Weisen Zeng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-06-30

2.  S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.

Authors:  Maite Martínez-Uña; Marta Varela-Rey; Daniela Mestre; Larraitz Fernández-Ares; Olatz Fresnedo; David Fernandez-Ramos; Virginia Gutiérrez-de Juan; Idoia Martin-Guerrero; Africa García-Orad; Zigmund Luka; Conrad Wagner; Shelly C Lu; Carmelo García-Monzón; Richard H Finnell; Igor Aurrekoetxea; Xabier Buqué; M Luz Martínez-Chantar; José M Mato; Patricia Aspichueta
Journal:  J Hepatol       Date:  2014-10-18       Impact factor: 25.083

3.  Integrin α1-null mice exhibit improved fatty liver when fed a high fat diet despite severe hepatic insulin resistance.

Authors:  Ashley S Williams; Li Kang; Jenny Zheng; Carrie Grueter; Deanna P Bracy; Freyja D James; Ambra Pozzi; David H Wasserman
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

4.  Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

Authors:  S Heebøll; M K Poulsen; M J Ornstrup; T N Kjær; S B Pedersen; S Nielsen; H Grønbæk; A Handberg
Journal:  Int J Obes (Lond)       Date:  2016-12-05       Impact factor: 5.095

5.  Hepatic Overexpression of CD36 Improves Glycogen Homeostasis and Attenuates High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance.

Authors:  Wojciech G Garbacz; Peipei Lu; Tricia M Miller; Samuel M Poloyac; Nicholas S Eyre; Graham Mayrhofer; Meishu Xu; Songrong Ren; Wen Xie
Journal:  Mol Cell Biol       Date:  2016-10-13       Impact factor: 4.272

6.  Hepatic fatty acid uptake is regulated by the sphingolipid acyl chain length.

Authors:  Woo-Jae Park; Joo-Won Park; Alfred H Merrill; Judith Storch; Yael Pewzner-Jung; Anthony H Futerman
Journal:  Biochim Biophys Acta       Date:  2014-12

7.  Abnormalities in the Metabolism of Fatty Acids and Triacylglycerols in the Liver of the Goto-Kakizaki Rat: A Model for Non-Obese Type 2 Diabetes.

Authors:  Minako Karahashi; Yuko Hirata-Hanta; Kohei Kawabata; Daisuke Tsutsumi; Misaki Kametani; Nanako Takamatsu; Takeshi Sakamoto; Tohru Yamazaki; Satoshi Asano; Atsushi Mitsumoto; Yoichi Kawashima; Naomi Kudo
Journal:  Lipids       Date:  2016-07-02       Impact factor: 1.880

8.  Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance.

Authors:  Pär Steneberg; Alexandros G Sykaras; Fredrik Backlund; Jurate Straseviciene; Ingegerd Söderström; Helena Edlund
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

9.  Lipid modulatory activities of Cichorium glandulosum Boiss et Huet are mediated by multiple components within hepatocytes.

Authors:  Lin Ding; Jun-Lin Liu; Waseem Hassan; Lu-Lu Wang; Fang-Rong Yan; Jing Shang
Journal:  Sci Rep       Date:  2014-05-06       Impact factor: 4.379

10.  Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease.

Authors:  Fareeba Sheedfar; Miranda My Sung; Marcela Aparicio-Vergara; Niels J Kloosterhuis; Maria Eugenia Miquilena-Colina; Javier Vargas-Castrillón; Maria Febbraio; René L Jacobs; Alain de Bruin; Manlio Vinciguerra; Carmelo García-Monzón; Marten H Hofker; Jason Rb Dyck; Debby P Y Koonen
Journal:  Aging (Albany NY)       Date:  2014-04       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.